Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin versus azithromycin + moxifloxacin for chlamydial cervicitis
IRCT20100130003226N16Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of azithromycin and moxifloxacin in Chlamydial cervicitis (4 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Status of patient's complaints, Status of clinical findings and 1 more. Started Nov 2018; status: completed.
02
Drugs
azithromycinmoxifloxacin
03
Conditions
Chlamydial cervicitis
Beyond the preview
Go deeper on IRCT20100130003226N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100130003226N16.